img

Global Prokinetic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prokinetic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
Prokinetic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prokinetic Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastroparesis and Constipation are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prokinetic Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prokinetic Drug key manufacturers include Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals and Hanmi Pharm, etc. Sumitomo, Johnson & Johnson, Sanofi are top 3 players and held % sales share in total in 2022.
Prokinetic Drug can be divided into Metoclopramide, Domperidone, Cisapride and Others, etc. Metoclopramide is the mainstream product in the market, accounting for % sales share globally in 2022.
Prokinetic Drug is widely used in various fields, such as Gastroparesis, Constipation, Reflux Esophagitis and Functional Dyspepsia, etc. Gastroparesis provides greatest supports to the Prokinetic Drug industry development. In 2022, global % sales of Prokinetic Drug went into Gastroparesis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prokinetic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
Segment by Type
Metoclopramide
Domperidone
Cisapride
Others

Segment by Application


Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prokinetic Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prokinetic Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prokinetic Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Prokinetic Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prokinetic Drug introduction, etc. Prokinetic Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prokinetic Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Prokinetic Drug Market Overview
1.1 Prokinetic Drug Product Overview
1.2 Prokinetic Drug Market Segment by Type
1.2.1 Metoclopramide
1.2.2 Domperidone
1.2.3 Cisapride
1.2.4 Others
1.3 Global Prokinetic Drug Market Size by Type
1.3.1 Global Prokinetic Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Prokinetic Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Prokinetic Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prokinetic Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Prokinetic Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Prokinetic Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Prokinetic Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Prokinetic Drug Sales Breakdown by Type (2024-2024)
2 Global Prokinetic Drug Market Competition by Company
2.1 Global Top Players by Prokinetic Drug Sales (2024-2024)
2.2 Global Top Players by Prokinetic Drug Revenue (2024-2024)
2.3 Global Top Players by Prokinetic Drug Price (2024-2024)
2.4 Global Top Manufacturers Prokinetic Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prokinetic Drug Market Competitive Situation and Trends
2.5.1 Prokinetic Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prokinetic Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prokinetic Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Prokinetic Drug Market
2.8 Key Manufacturers Prokinetic Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prokinetic Drug Status and Outlook by Region
3.1 Global Prokinetic Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Prokinetic Drug Historic Market Size by Region
3.2.1 Global Prokinetic Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Prokinetic Drug Sales in Value by Region (2024-2024)
3.2.3 Global Prokinetic Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Prokinetic Drug Forecasted Market Size by Region
3.3.1 Global Prokinetic Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Prokinetic Drug Sales in Value by Region (2024-2034)
3.3.3 Global Prokinetic Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Prokinetic Drug by Application
4.1 Prokinetic Drug Market Segment by Application
4.1.1 Gastroparesis
4.1.2 Constipation
4.1.3 Reflux Esophagitis
4.1.4 Functional Dyspepsia
4.2 Global Prokinetic Drug Market Size by Application
4.2.1 Global Prokinetic Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Prokinetic Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Prokinetic Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prokinetic Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Prokinetic Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Prokinetic Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Prokinetic Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Prokinetic Drug Sales Breakdown by Application (2024-2024)
5 North America Prokinetic Drug by Country
5.1 North America Prokinetic Drug Historic Market Size by Country
5.1.1 North America Prokinetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Prokinetic Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Prokinetic Drug Sales in Value by Country (2024-2024)
5.2 North America Prokinetic Drug Forecasted Market Size by Country
5.2.1 North America Prokinetic Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Prokinetic Drug Sales in Value by Country (2024-2034)
6 Europe Prokinetic Drug by Country
6.1 Europe Prokinetic Drug Historic Market Size by Country
6.1.1 Europe Prokinetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Prokinetic Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Prokinetic Drug Sales in Value by Country (2024-2024)
6.2 Europe Prokinetic Drug Forecasted Market Size by Country
6.2.1 Europe Prokinetic Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Prokinetic Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Prokinetic Drug by Region
7.1 Asia-Pacific Prokinetic Drug Historic Market Size by Region
7.1.1 Asia-Pacific Prokinetic Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Prokinetic Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Prokinetic Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Prokinetic Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Prokinetic Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Prokinetic Drug Sales in Value by Region (2024-2034)
8 Latin America Prokinetic Drug by Country
8.1 Latin America Prokinetic Drug Historic Market Size by Country
8.1.1 Latin America Prokinetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Prokinetic Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Prokinetic Drug Sales in Value by Country (2024-2024)
8.2 Latin America Prokinetic Drug Forecasted Market Size by Country
8.2.1 Latin America Prokinetic Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Prokinetic Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Prokinetic Drug by Country
9.1 Middle East and Africa Prokinetic Drug Historic Market Size by Country
9.1.1 Middle East and Africa Prokinetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Prokinetic Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Prokinetic Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Prokinetic Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Prokinetic Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Prokinetic Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sumitomo
10.1.1 Sumitomo Company Information
10.1.2 Sumitomo Introduction and Business Overview
10.1.3 Sumitomo Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Sumitomo Prokinetic Drug Products Offered
10.1.5 Sumitomo Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Johnson & Johnson Prokinetic Drug Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sanofi Prokinetic Drug Products Offered
10.3.5 Sanofi Recent Development
10.4 Kyowa Kirin Pharmaceuticals
10.4.1 Kyowa Kirin Pharmaceuticals Company Information
10.4.2 Kyowa Kirin Pharmaceuticals Introduction and Business Overview
10.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Products Offered
10.4.5 Kyowa Kirin Pharmaceuticals Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer Prokinetic Drug Products Offered
10.5.5 Pfizer Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Teva Prokinetic Drug Products Offered
10.6.5 Teva Recent Development
10.7 Cadila Pharmaceuticals
10.7.1 Cadila Pharmaceuticals Company Information
10.7.2 Cadila Pharmaceuticals Introduction and Business Overview
10.7.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Cadila Pharmaceuticals Prokinetic Drug Products Offered
10.7.5 Cadila Pharmaceuticals Recent Development
10.8 Hanmi Pharm
10.8.1 Hanmi Pharm Company Information
10.8.2 Hanmi Pharm Introduction and Business Overview
10.8.3 Hanmi Pharm Prokinetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Hanmi Pharm Prokinetic Drug Products Offered
10.8.5 Hanmi Pharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prokinetic Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prokinetic Drug Industrial Chain Analysis
11.4 Prokinetic Drug Market Dynamics
11.4.1 Prokinetic Drug Industry Trends
11.4.2 Prokinetic Drug Market Drivers
11.4.3 Prokinetic Drug Market Challenges
11.4.4 Prokinetic Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prokinetic Drug Distributors
12.3 Prokinetic Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Metoclopramide
Table 2. Major Company of Domperidone
Table 3. Major Company of Cisapride
Table 4. Major Company of Others
Table 5. Global Prokinetic Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Prokinetic Drug Sales by Type (2024-2024) & (K Units)
Table 7. Global Prokinetic Drug Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Prokinetic Drug Sales by Type (2024-2024) & (US& Million)
Table 9. Global Prokinetic Drug Market Share in Value by Type (2024-2024)
Table 10. Global Prokinetic Drug Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Prokinetic Drug Sales by Type (2024-2034) & (K Units)
Table 12. Global Prokinetic Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Prokinetic Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Prokinetic Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Prokinetic Drug Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Prokinetic Drug Sales by Type (2024-2024) & (K Units)
Table 17. North America Prokinetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Prokinetic Drug Sales (K Units) by Type (2024-2024)
Table 19. Europe Prokinetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Prokinetic Drug Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Prokinetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Prokinetic Drug Sales (K Units) by Type (2024-2024)
Table 23. Latin America Prokinetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Prokinetic Drug Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Prokinetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Prokinetic Drug Sales by Company (2024-2024) & (K Units)
Table 27. Global Prokinetic Drug Sales Share by Company (2024-2024)
Table 28. Global Prokinetic Drug Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Prokinetic Drug Revenue Share by Company (2024-2024)
Table 30. Global Market Prokinetic Drug Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Prokinetic Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Prokinetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prokinetic Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Prokinetic Drug Market
Table 35. Key Manufacturers Prokinetic Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Prokinetic Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Prokinetic Drug Sales by Region (2024-2024) & (K Units)
Table 39. Global Prokinetic Drug Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Prokinetic Drug Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Prokinetic Drug Sales Market Share in Value by Region (2024-2024)
Table 42. Global Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Prokinetic Drug Sales by Region (2024-2034) & (K Units)
Table 44. Global Prokinetic Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Prokinetic Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Prokinetic Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Prokinetic Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Prokinetic Drug Sales by Application (2024-2024) & (K Units)
Table 50. Global Prokinetic Drug Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Prokinetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Prokinetic Drug Sales Market Share in Value by Application (2024-2024)
Table 53. Global Prokinetic Drug Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Prokinetic Drug Sales by Application (2024-2034) & (K Units)
Table 55. Global Prokinetic Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Prokinetic Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Prokinetic Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Prokinetic Drug Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Prokinetic Drug Sales by Application (2024-2024) (K Units)
Table 60. North America Prokinetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Prokinetic Drug Sales by Application (2024-2024) (K Units)
Table 62. Europe Prokinetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Prokinetic Drug Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Prokinetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Prokinetic Drug Sales by Application (2024-2024) (K Units)
Table 66. Latin America Prokinetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Prokinetic Drug Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Prokinetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Prokinetic Drug Sales by Country (2024-2024) & (K Units)
Table 70. North America Prokinetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Prokinetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Prokinetic Drug Sales Market Share in Value by Country (2024-2024)
Table 73. North America Prokinetic Drug Sales by Country (2024-2034) & (K Units)
Table 74. North America Prokinetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Prokinetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Prokinetic Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Prokinetic Drug Sales by Country (2024-2024) & (K Units)
Table 78. Europe Prokinetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Prokinetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Prokinetic Drug Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Prokinetic Drug Sales by Country (2024-2034) & (K Units)
Table 82. Europe Prokinetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Prokinetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Prokinetic Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Prokinetic Drug Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Prokinetic Drug Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Prokinetic Drug Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Prokinetic Drug Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Prokinetic Drug Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Prokinetic Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Prokinetic Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Prokinetic Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Prokinetic Drug Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Prokinetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Prokinetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Prokinetic Drug Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Prokinetic Drug Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Prokinetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Prokinetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Prokinetic Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Prokinetic Drug Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Prokinetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Prokinetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Prokinetic Drug Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Prokinetic Drug Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Prokinetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Prokinetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Prokinetic Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Sumitomo Company Information
Table 110. Sumitomo Introduction and Business Overview
Table 111. Sumitomo Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Sumitomo Prokinetic Drug Product
Table 113. Sumitomo Recent Development
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Introduction and Business Overview
Table 116. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Johnson & Johnson Prokinetic Drug Product
Table 118. Johnson & Johnson Recent Development
Table 119. Sanofi Company Information
Table 120. Sanofi Introduction and Business Overview
Table 121. Sanofi Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Sanofi Prokinetic Drug Product
Table 123. Sanofi Recent Development
Table 124. Kyowa Kirin Pharmaceuticals Company Information
Table 125. Kyowa Kirin Pharmaceuticals Introduction and Business Overview
Table 126. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product
Table 128. Kyowa Kirin Pharmaceuticals Recent Development
Table 129. Pfizer Company Information
Table 130. Pfizer Introduction and Business Overview
Table 131. Pfizer Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Pfizer Prokinetic Drug Product
Table 133. Pfizer Recent Development
Table 134. Teva Company Information
Table 135. Teva Introduction and Business Overview
Table 136. Teva Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Teva Prokinetic Drug Product
Table 138. Teva Recent Development
Table 139. Cadila Pharmaceuticals Company Information
Table 140. Cadila Pharmaceuticals Introduction and Business Overview
Table 141. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. Cadila Pharmaceuticals Prokinetic Drug Product
Table 143. Cadila Pharmaceuticals Recent Development
Table 144. Hanmi Pharm Company Information
Table 145. Hanmi Pharm Introduction and Business Overview
Table 146. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Hanmi Pharm Prokinetic Drug Product
Table 148. Hanmi Pharm Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Prokinetic Drug Market Trends
Table 152. Prokinetic Drug Market Drivers
Table 153. Prokinetic Drug Market Challenges
Table 154. Prokinetic Drug Market Restraints
Table 155. Prokinetic Drug Distributors List
Table 156. Prokinetic Drug Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Prokinetic Drug Product Picture
Figure 2. Global Prokinetic Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prokinetic Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Prokinetic Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Metoclopramide
Figure 6. Global Metoclopramide Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Domperidone
Figure 8. Global Domperidone Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Cisapride
Figure 10. Global Cisapride Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Prokinetic Drug Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Prokinetic Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Prokinetic Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Prokinetic Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Prokinetic Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Prokinetic Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Prokinetic Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Prokinetic Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Prokinetic Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Prokinetic Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Prokinetic Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Prokinetic Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Prokinetic Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Prokinetic Drug Revenue in 2022
Figure 27. Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Gastroparesis
Figure 29. Global Gastroparesis Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Constipation
Figure 31. Global Constipation Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Reflux Esophagitis
Figure 33. Global Reflux Esophagitis Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Functional Dyspepsia
Figure 35. Global Functional Dyspepsia Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Prokinetic Drug Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Prokinetic Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Prokinetic Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Prokinetic Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Prokinetic Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Prokinetic Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Prokinetic Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Prokinetic Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Prokinetic Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Prokinetic Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Prokinetic Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Prokinetic Drug Manufacturing Cost Structure
Figure 49. Prokinetic Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed